4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-038774
EVP & Chief Commercial Officer sold 295 shares at $54.78 ($16,160)
From the SEC's structured data for this filing
Trades in this filing
Harris Erik · EVP & Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-06-19 | Sale : show line 1 in the form | −295 | $54.78 | $16,160 | 36,160 | D |
| Open-market sales · 295 sh · avg $54.78 · $16,160 | ||||||
Loading xslF345X03/doc4.xml…